Unlocking a Combination Therapy for New Onset T1D

Next month, a new study will start to further assess if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a combination of two U.S Food and Drug Administration (FDA) approved drugs, antithymocyte globulin (ATG) and […]

One on One – December

One on One – December

We are so proud of Cami Lange, a Youth Ambassador for the Florida Suncoast Chapter, she was featured in the November issue of Neapolitan Family with an article about living well with diabetes. Cami who was diagnosed at just 4 years old and is now a sophomore in high school talks about what it’s like […]

A song worth more than a listen

Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]

Advancing a Key Artificial Pancreas Technology

Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP systems that better mimic the biological function of the pancreas and reduce the daily burden of managing type 1 diabetes (T1D). To achieve this goal, JDRF funds […]

Improving Beta Cell Health and Survival

JDRF-funded clinical study to test marketed drug to improve beta cell health and survival in T1D JDRF recently awarded a $2.1 million grant to Anath Shalev, M.D., director of the University of Alabama’s (UAB) Comprehensive Diabetes Center, to test the impact of a common blood pressure drug called verapamil on the health and survival of […]

Historic Progress for JDRF Encapsulation Research Program

First people with type 1 diabetes receive experimental encapsulated cell replacement therapies in clinical studies Two JDRF-funded partners have successfully implanted people with type 1 diabetes (T1D) with experimental encapsulated cell replacement therapies in clinical studies. These two programs are running in parallel and are evaluating two distinct encapsulation therapies. Encapsulated cell replacement therapy involves […]

Making the T1D Vaccine a Reality

Nanoparticle-based vaccine is designed to re-educate the immune system and halt the attack on the pancreas Over the last three years, Selecta Bioscience, a clinical stage biotechnology company, has been developing nanoparticles called Synthetic Vaccine Particle (SVP) as an immunotherapy for Type 1 diabetes (T1D) with support from JDRF and it was announced this week […]

JDRF-Funded Research Leads to Beta Cell Replacement Breakthrough

A new method for converting stem cells to beta cells could speed encapsulated cell replacement product development and research to cure type 1 diabetes Insulin therapy has long been the only method of treating type 1 diabetes (T1D), but a major breakthrough in producing replacement beta cells is bringing new hope that more effective, alternative […]

Florida Suncoast Youth Ambassador Program

Florida Suncoast Youth Ambassador Program

Thank you to Tricia Wilkinson and Michelle Lang! Tricia and Michelle have taken over the Youth Ambassador Program for our chapter. They are looking for two parents to help out and represent the northern end of our chapter to help with the program. If interested, please contact Tricia at Wilkinsonzoo@earthlink.net If your child has been […]